Dr. Jean Hoffman-Censits on the Results of a Phase II Trial Studying Atezolizumab in Bladder Cancer
Jean Hoffman-Censits (@JCensits) / X
Bladder Cancer and Cancer Immunotherapy: A New Path Forward
Jean Hoffman-Censits, MD - Johns Hopkins Medicine
Jean Hoffman-Censits (@JCensits) / X
Jean Hoffman-Censits | Cancer Matters
Jean HOFFMAN-CENSITS | Thomas Jefferson University, Philadelphia | Jefferson | Department of Medical Oncology | Research profile
Jean Hoffman-Censits on Twitter: "A little late to the party, but the whole family even the pups came out to spread the word in Baltimore! Thank you BCAN for all you do
Atezolizumab generates excitement in advanced urothelial cancer | MDedge Hematology and Oncology
Jefferson Health - On the blog: With Bladder Cancer Awareness Month coming up in May, we spoke with Dr. Jean Hoffman-Censits, M.D. Director of the Genitourinary Multidisciplinary Cancer Clinic Department of Medical
Jean Hoffman-Censits | PracticeUpdate
Jean Hoffman-Censits - Co-Director, Women's Bladder Cancer Program - Sidney Kimmel Cancer Center at Johns Hopkins | LinkedIn
Jean Heather Hoffman-Censits, M.D., Associate Professor of Oncology | Johns Hopkins Medicine
Jean Hoffman-Censits - Co-Director, Women's Bladder Cancer Program - Sidney Kimmel Cancer Center at Johns Hopkins | LinkedIn
Dr. Jean Hoffman-Censits, MD, Medical Oncology Specialist - Baltimore, MD | Sharecare
A Novel Study for Patients with Small Cell Bladder Cancer - Johns Hopkins Medicine
ESMO Virtual Congress 2020: Real-World Evidence of the Impact of Prior Autoimmune Disease on Immune Checkpoint Inhibitor Outcomes in Patients with Metastatic Urothelial Cancer
Jean Hoffman-Censits (@JCensits) / X
Jean Hoffman-Censits (@JCensits) / X
Dr. Hoffman-Censits on Biomarker Development in Urothelial Carcinoma - YouTube
Dr. Jean (Hoffman) Hoffman-Censits, MD – Baltimore, MD | Oncology
Dr. Jean Hoffman-Censits on the Results of a Phase II Trial Studying Atezolizumab in Bladder Cancer - YouTube
